BETWEENDevelopment and Commercialization Agreement • October 21st, 2005 • Predix Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Maryland
Contract Type FiledOctober 21st, 2005 Company Industry Jurisdiction
AGREEMENT by and between HYBRIDON, INC. andDevelopment and Commercialization Agreement • August 9th, 2005 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 9th, 2005 Company Industry Jurisdiction
BETWEENDevelopment and Commercialization Agreement • August 3rd, 2005 • Predix Pharmaceuticals Holdings Inc • Maryland
Contract Type FiledAugust 3rd, 2005 Company Jurisdiction
TESTOSTERONE DEVELOPMENT AND COMMERCIALIZATION AGREEMENT ---------------------- ----------------------------------------------------------Development and Commercialization Agreement • May 7th, 2004 • Vivus Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledMay 7th, 2004 Company Industry Jurisdiction
INTRODUCTIONDevelopment and Commercialization Agreement • October 28th, 2003 • Myogen Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 28th, 2003 Company Industry Jurisdiction
RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT/1/Development and Commercialization Agreement • October 14th, 2003 • Cambridge Antibody Technology Group PLC • Services-commercial physical & biological research • New York
Contract Type FiledOctober 14th, 2003 Company Industry Jurisdiction
INTRODUCTIONDevelopment and Commercialization Agreement • October 9th, 2003 • Myogen Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 9th, 2003 Company Industry Jurisdiction
BetweenDevelopment and Commercialization Agreement • October 2nd, 2003 • Aderis Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 2nd, 2003 Company Industry Jurisdiction
Exhibit 10.37 * The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange...Development and Commercialization Agreement • May 15th, 2003 • Guilford Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2003 Company Industry Jurisdiction
QLT INC. AND XENOVA LIMITEDDevelopment and Commercialization Agreement • March 28th, 2003 • QLT Inc/Bc • Pharmaceutical preparations • England
Contract Type FiledMarch 28th, 2003 Company Industry Jurisdiction
Exhibit 10.31 THIRD AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • November 14th, 2002 • Durect Corp • Pharmaceutical preparations • California
Contract Type FiledNovember 14th, 2002 Company Industry Jurisdiction
EXHIBIT 10.75 DEVELOPMENT AND COMMERCIALIZATION AGREEMENT This Development and Commercialization Agreement ("AGREEMENT") is entered into with effect from the 13th day of August, 2001 (the "EFFECTIVE DATE") between QLT Inc. ("QLT"), a company...Development and Commercialization Agreement • November 13th, 2002 • QLT Inc/Bc • Pharmaceutical preparations • England
Contract Type FiledNovember 13th, 2002 Company Industry Jurisdiction
BetweenDevelopment and Commercialization Agreement • April 25th, 2002 • Aderis Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 25th, 2002 Company Industry Jurisdiction
CONFIDENTIAL DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN THIRD WAVE TECHNOLOGIES, INC.Development and Commercialization Agreement • April 1st, 2002 • Aclara Biosciences Inc • Measuring & controlling devices, nec • California
Contract Type FiledApril 1st, 2002 Company Industry Jurisdiction
RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT/1/Development and Commercialization Agreement • February 21st, 2002 • Cambridge Antibody Technology Group PLC • Services-commercial physical & biological research • New York
Contract Type FiledFebruary 21st, 2002 Company Industry Jurisdiction
BetweenDevelopment and Commercialization Agreement • January 11th, 2002 • Aderis Pharmaceuticals Inc • New York
Contract Type FiledJanuary 11th, 2002 Company Jurisdiction
RECITALSDevelopment and Commercialization Agreement • November 5th, 2001 • Molichem Medicines Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 5th, 2001 Company Industry Jurisdiction
EXHIBIT 10.38 RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • March 30th, 2001 • 3 Dimensional Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 30th, 2001 Company Industry Jurisdiction
RECITALSDevelopment and Commercialization Agreement • March 30th, 2001 • Aradigm Corp • Electromedical & electrotherapeutic apparatus
Contract Type FiledMarch 30th, 2001 Company Industry
EXHIBIT 10.6 SECOND AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • September 1st, 2000 • Durect Corp • Pharmaceutical preparations • California
Contract Type FiledSeptember 1st, 2000 Company Industry Jurisdiction
CONFIDENTIAL EXHIBIT 10.6 SECOND AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • April 20th, 2000 • Durect Corp • California
Contract Type FiledApril 20th, 2000 Company Jurisdiction
WITNESSETH:Development and Commercialization Agreement • April 9th, 1999 • Spectrx Inc • Electromedical & electrotherapeutic apparatus • Georgia
Contract Type FiledApril 9th, 1999 Company Industry Jurisdiction
1 EXHIBIT 10.24 DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • November 20th, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 20th, 1997 Company Industry Jurisdiction
EXHIBIT 10.6 DEVELOPMENT AND COMMERCIALIZATION AGREEMENT THIS DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (together with the attached Schedules, the "Agreement") is made as of this 25th day of September, 1997 (the "Effective Date") by and between...Development and Commercialization Agreement • November 5th, 1997 • Genzyme Transgenics Corp • Biological products, (no disgnostic substances)
Contract Type FiledNovember 5th, 1997 Company Industry
1 EXHIBIT 10.24 DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • March 31st, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 31st, 1997 Company Industry Jurisdiction